LFST logo

LifeStance Health Group, Inc. (LFST) EBITDA

Annual EBITDA:

$40.49M+$147.40M(+137.87%)
December 31, 2024

Summary

  • As of today, LFST annual EBITDA is $40.49 million, with the most recent change of +$147.40 million (+137.87%) on December 31, 2024.
  • During the last 3 years, LFST annual EBITDA has risen by +$269.52 million (+117.68%).
  • LFST annual EBITDA is now -12.88% below its all-time high of $46.48 million, reached on December 31, 2020.

Performance

LFST EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherLFSTincome statement metrics

Quarterly EBITDA:

$21.54M+$9.90M(+85.00%)
September 30, 2025

Summary

  • As of today, LFST quarterly EBITDA is $21.54 million, with the most recent change of +$9.90 million (+85.00%) on September 30, 2025.
  • Over the past year, LFST quarterly EBITDA has increased by +$6.24 million (+40.81%).
  • LFST quarterly EBITDA is now at all-time high.

Performance

LFST Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherLFSTincome statement metrics

TTM EBITDA:

$64.44M+$6.24M(+10.73%)
September 30, 2025

Summary

  • As of today, LFST TTM EBITDA is $64.44 million, with the most recent change of +$6.24 million (+10.73%) on September 30, 2025.
  • Over the past year, LFST TTM EBITDA has increased by +$49.30 million (+325.47%).
  • LFST TTM EBITDA is now at all-time high.

Performance

LFST TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherLFSTincome statement metrics

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

LFST EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+137.9%+40.8%+325.5%
3Y3 Years+117.7%+207.2%+131.0%
5Y5 Years+89.8%+58.4%+147.0%

LFST EBITDA Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Yearat high+117.7%at high+139.5%at high+131.0%
5Y5-Year-12.9%+117.7%at high+119.6%at high+121.7%
All-TimeAll-Time-12.9%+117.7%at high+119.6%at high+121.7%

LFST EBITDA History

DateAnnualQuarterlyTTM
Sep 2025
-
$21.54M(+85.0%)
$64.44M(+10.7%)
Jun 2025
-
$11.64M(-25.3%)
$58.20M(+17.4%)
Mar 2025
-
$15.59M(-0.5%)
$49.59M(+24.3%)
Dec 2024
$40.49M(+137.9%)
$15.67M(+2.5%)
$39.89M(+163.4%)
Sep 2024
-
$15.30M(+404.2%)
$15.15M(+127.7%)
Jun 2024
-
$3.03M(-48.5%)
-$54.67M(+36.6%)
Mar 2024
-
$5.89M(+164.9%)
-$86.29M(+19.3%)
Dec 2023
-$106.91M(+21.9%)
-$9.07M(+83.4%)
-$106.91M(+14.0%)
Sep 2023
-
-$54.52M(-90.7%)
-$124.39M(-38.3%)
Jun 2023
-
-$28.59M(-94.0%)
-$89.95M(+13.7%)
Mar 2023
-
-$14.73M(+44.5%)
-$104.24M(+23.8%)
Dec 2022
-$136.88M
-$26.55M(-32.1%)
-$136.88M(+34.1%)
DateAnnualQuarterlyTTM
Sep 2022
-
-$20.09M(+53.1%)
-$207.63M(+30.2%)
Jun 2022
-
-$42.88M(+9.5%)
-$297.54M(-3.0%)
Mar 2022
-
-$47.37M(+51.3%)
-$288.93M(-25.5%)
Dec 2021
-$229.03M(-592.7%)
-$97.29M(+11.6%)
-$230.21M(-73.2%)
Sep 2021
-
-$110.00M(-221.0%)
-$132.92M(-1325.7%)
Jun 2021
-
-$34.27M(-402.0%)
-$9.32M(-130.8%)
Mar 2021
-
$11.35M(-16.6%)
$30.23M(+15.9%)
Dec 2020
$46.48M(+117.9%)
-
-
Sep 2020
-
$13.60M(+157.5%)
$26.09M(+108.9%)
Jun 2020
-
$5.28M(-26.8%)
$12.49M(+73.2%)
Mar 2020
-
$7.21M
$7.21M
Dec 2019
$21.34M
-
-

FAQ

  • What is LifeStance Health Group, Inc. annual EBITDA?
  • What is the all-time high annual EBITDA for LifeStance Health Group, Inc.?
  • What is LifeStance Health Group, Inc. annual EBITDA year-on-year change?
  • What is LifeStance Health Group, Inc. quarterly EBITDA?
  • What is the all-time high quarterly EBITDA for LifeStance Health Group, Inc.?
  • What is LifeStance Health Group, Inc. quarterly EBITDA year-on-year change?
  • What is LifeStance Health Group, Inc. TTM EBITDA?
  • What is the all-time high TTM EBITDA for LifeStance Health Group, Inc.?
  • What is LifeStance Health Group, Inc. TTM EBITDA year-on-year change?

What is LifeStance Health Group, Inc. annual EBITDA?

The current annual EBITDA of LFST is $40.49M

What is the all-time high annual EBITDA for LifeStance Health Group, Inc.?

LifeStance Health Group, Inc. all-time high annual EBITDA is $46.48M

What is LifeStance Health Group, Inc. annual EBITDA year-on-year change?

Over the past year, LFST annual EBITDA has changed by +$147.40M (+137.87%)

What is LifeStance Health Group, Inc. quarterly EBITDA?

The current quarterly EBITDA of LFST is $21.54M

What is the all-time high quarterly EBITDA for LifeStance Health Group, Inc.?

LifeStance Health Group, Inc. all-time high quarterly EBITDA is $21.54M

What is LifeStance Health Group, Inc. quarterly EBITDA year-on-year change?

Over the past year, LFST quarterly EBITDA has changed by +$6.24M (+40.81%)

What is LifeStance Health Group, Inc. TTM EBITDA?

The current TTM EBITDA of LFST is $64.44M

What is the all-time high TTM EBITDA for LifeStance Health Group, Inc.?

LifeStance Health Group, Inc. all-time high TTM EBITDA is $64.44M

What is LifeStance Health Group, Inc. TTM EBITDA year-on-year change?

Over the past year, LFST TTM EBITDA has changed by +$49.30M (+325.47%)
On this page